Replicate Bioscience, Inc.

Name: Replicate Bioscience, Inc.
Address: 10210 Campus Point Dr, San Diego, California, United States, 92121, San Diego
Telephone: '+1 619-786-7702

San Diegobiotechnology

About

Replicate Bioscience, Inc. is a clinical-stage biotechnology company based in San Diego, California, founded in 2020. The company specializes in self-replicating RNA (srRNA) technology to develop therapies for infectious diseases, oncology, and autoimmune disorders. Their innovative srRNA vectors enable cells to produce natural RNA repeatedly, leading to enhanced protein expression and long-lasting therapeutic effects. The company's lead candidate, RBI-4000, is a rabies vaccine currently in Phase 1 trials, demonstrating strong immunogenicity and safety. Replicate also has a pipeline of preclinical candidates targeting various health challenges, including drug-resistant cancer mutations. The company holds 10 patents in biotechnology and has raised a total of $46 million in funding. Replicate is focused on advancing its internal pipeline and has established partnerships, including a collaboration with Instituto Butantan for the development of RBI-4000 in Latin America. With a small team of fewer than 25 employees, Replicate is positioned as an emerging player in RNA therapeutics.